medline.ch Onkologie Gynäkologische Tumoren

	Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission. Biochim Biophys Acta Rev Cancer Tyagi K, Mandal S, Roy A. PMID: 33971276 [PubMed - as supplied by publisher]
	Nanodiamonds and their potential applications in breast cancer therapy: a narrative review. Drug Deliv Transl Res Tjo K, Varamini P. PMID: 33970463 [PubMed - as supplied by publisher]
	Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Fam Cancer Meiser B, Woodward P, Gleeson M, Kentwell M, Fan HM, Antill Y, Butow PN, Boyle F, Best M, Taylor N, Bell K, Tucker K. PMID: 33970363 [PubMed - as supplied by publisher]
	A Breast Cancer Smartphone App to Navigate the Breast Cancer Journey: Mixed Methods Study. JMIR Form Res Petrocchi S, Filipponi C, Montagna G, Bonollo M, Pagani O, Meani F. PMID: 33970120 [PubMed - as supplied by publisher]
	Detection of acquired radioresistance in breast cancer cell lines using Raman spectroscopy and machine learning. Analyst Tipatet KS, Davison-Gates L, Tewes TJ, Fiagbedzi EK, Elfick A, Neu B, Downes A. PMID: 33969839 [PubMed - as supplied by publisher]
	Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer. Int J Gynaecol Obstet D'Alessandro G, Frigerio M, Barra F, Costantini S, Gustavino C, Ferrero S. PMID: 33969485 [PubMed - as supplied by publisher]
	SUMOylation Wrestles With the Occurrence and Development of Breast Cancer. Front Oncol Qin Y, Yuan H, Chen X, Yang X, Xing Z, Shen Y, Dong W, An S, Qi Y, Wu H. PMID: 33968766 [PubMed]
	Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer. Front Oncol Zhao Y, Zheng X, Zheng Y, Chen Y, Fei W, Wang F, Zheng C. PMID: 33968752 [PubMed]
	SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer. Front Oncol Pascual T, Oliveira M, Ciruelos E, Bellet Ezquerra M, Saura C, Gavilá J, Pernas S, Muñoz M, Vidal MJ, Margelí Vila M, Cejalvo JM, González-Farré B, Espinosa-Bravo M, Cruz J, Salvador-Bofill FJ, Guerra JA, Luna Barrera AM, Arumi de Dios M, Esker S, Fan PD, Martínez-Sáez O, Villacampa G, Paré L, Ferrero-Cafiero JM, Villagrasa P, Prat A. PMID: 33968735 [PubMed]
	The role of ultrasound elastography and virtual touch tissue imaging in the personalized prediction of lymph node metastasis of breast cancer. Gland Surg Wang J, Ben Z, Gao S, Lyu S, Wei X. PMID: 33968697 [PubMed]
	The effectiveness of axillary reverse mapping in preventing breast cancer-related lymphedema: a meta-analysis based on randomized controlled trials. Gland Surg Guo X, Jiao D, Zhu J, Xiao H, Zhao X, Yang Y, Zhao Y, Liu Z. PMID: 33968696 [PubMed]
	The significance of coagulation and fibrinolysis-related parameters in predicting postoperative venous thrombosis in patients with breast cancer. Gland Surg Pang M, Zhao F, Yu P, Zhang X, Xiao H, Qiang W, Zhu H, Zhao L. PMID: 33968695 [PubMed]
	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from breast cancer: a preliminary report of 4 cases. Gland Surg Yu JH, Feng Y, Li XB, Zhang CY, Shi F, An SL, Liu G, Zhang YB, Zhang K, Ji ZH, Li B, Yan GJ, Li YP, Li Y. PMID: 33968683 [PubMed]
	Exploring the endogenous potential of Hemidesmus indicus against breast cancer using in silico studies and quantification of 2-hydroxy-4-methoxy benzaldehyde through RP-HPLC. 3 Biotech Bansod AA, Ramasamy G, Nathan B, Kandhasamy R, Palaniappan M, Vichangal Pridiuldi S. PMID: 33968579 [PubMed]
	Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence. J Gastrointest Oncol Spiliotis J, Prodromidou A. PMID: 33968436 [PubMed]
	Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience. J Gastrointest Oncol Coccolini F, Fugazzola P, Montori G, Ansaloni L, Chiarugi M. PMID: 33968435 [PubMed]
	Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer. J Gastrointest Oncol Boerner T, Zivanovic O, Chi DS. PMID: 33968434 [PubMed]
	ESMO 2020: highlights in breast cancer. Memo Bartsch R. PMID: 33968263 [PubMed]
	Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer. Front Immunol Mehta AK, Kadel S, Townsend MG, Oliwa M, Guerriero JL. PMID: 33968034 [PubMed - in process]
	The application of personalized rehabilitation exercises in the postoperative rehabilitation of breast cancer patients. Ann Palliat Med Huo H, Wang Q, Zhou S, Cui L. PMID: 33966396 [PubMed - in process]

Artikel 1 - 20 / 240103

Seite 1 von 12006

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung